Status:
NOT_YET_RECRUITING
Conserving Surgery in Inflammatory Breast Cancer After Neoadjuvant Chemotherapy
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
Inflammatory Breast Cancer
Eligibility:
FEMALE
18-70 years
Phase:
NA
Brief Summary
Inflammatory breast cancer is an aggressive and rare form of breast cancer, which accounts for 2-3% of all breast cancers. The classic presentation of inflammatory breast cancer includes erythema, ede...
Eligibility Criteria
Inclusion
- Patients with inflammatory breast cancer
- Clinical complete response after neoadjuvant chemiotherapy
- Targeted tumor
- Written informed consent
Exclusion
- Metastasis
- Progression disease
- Recurrent disease
- Contraindications to adjuvant radiation therapy
Key Trial Info
Start Date :
March 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2028
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06131632
Start Date
March 1 2024
End Date
January 1 2028
Last Update
January 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione Policlinico Universitario A. Gemelli IRCCS,
Roma, Italy, 00168